GlassScriptPhysician profile
Denes Korpas
NPI 1902992399
$9,444.72
in general payments reported to CMS, 2019-2025
34 companies · $3,469 in 2025
The $3,469 reported for 2025 was more than what 78% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,854 · 2020: $361 · 2021: $498 · 2022: $604 · 2023: $1,230 · 2024: $1,429 · 2025: $3,469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,895 · Travel and Lodging: $1,233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,894.77 |
| Travel and Lodging | $1,233.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,813.95 | 2019-2025 | General - Therapies, Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd |
| Medtronic, INC. | $2,344.27 | 2021-2025 | Azure Xt Dr Mri Surescan, Corevalve Evolut R, Symplicity G3 |
| Impulse Dynamics (USA) INC. | $799.24 | 2022-2025 | Optimizer, Optimizer |
| Novartis Pharmaceuticals Corporation | $511.95 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $411.72 | 2020-2025 | Camzyos |
| Sanofi-Aventis U.S. LLC | $292.10 | 2019-2023 | |
| Amgen INC. | $237.47 | 2019-2025 | Repatha |
| Pfizer INC. | $206.72 | 2021-2025 | |
| Esperion Therapeutics, INC. | $204.08 | 2020-2024 | Nexletol |
| Medtronic Vascular, INC. | $162.99 | 2019 | |
| Janssen Pharmaceuticals, INC | $144.00 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.61 | 2019-2024 | Jardiance |
| Novo Nordisk INC | $128.72 | 2021-2024 | Ozempic, Wegovy, Rybelsus |
| Heartflow, INC. | $124.30 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $112.70 | 2021-2024 | Verquvo, Bridion |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $103.65 | 2022-2023 | Watchpatone |
| Abbott Laboratories | $86.48 | 2023-2024 | Navitor, Esprit |
| Edwards Lifesciences Corporation | $63.36 | 2022-2025 | Sapien 3 Ultra Resilia |
| Chiesi USA, INC. | $58.08 | 2019-2024 | Kengreal, Cleviprex |
| Lexicon Pharmaceuticals, INC. | $55.62 | 2023-2024 | Inpefa |
| Astrazeneca Pharmaceuticals LP | $51.80 | 2021-2025 | Farxiga, Brilinta |
| Amarin Pharma, INC. | $49.52 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $49.50 | 2019-2025 | Evkeeza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.93 | 2023-2024 | Lifevest |
| Baxter Healthcare | $45.66 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Teleflex LLC | $39.56 | 2025 | Guideliner, Trapliner |
| Philips North America LLC | $28.89 | 2024 | (5044) Mcot |
| Actelion Pharmaceuticals US, INC. | $27.79 | 2021 | |
| Bridgebio Pharma, INC. | $26.87 | 2025 | Attruby |
| Bayer Healthcare Pharmaceuticals INC. | $26.69 | 2022-2025 | |
| Biotronik INC. | $21.60 | 2019 | |
| Gilead Sciences, INC. | $15.20 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.65 | 2021 | |
| Lundbeck LLC | $11.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denes Korpas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.